Nathan A. Pennell
Lung cancer oncologist who has pushed for universal biomarker testing and better trial design.
Leads lung cancer clinical research at Cleveland Clinic; ASCO educational leader on molecular testing in NSCLC.
| Title | Journal | Year |
|---|---|---|
| Biomarker testing for patients with advanced non-small cell lung cancer: real-world issues and tough choices | ASCO Educational Book | 2019 |
Pages like this
not linked directly; found by shared links- PersonTimothy A. Chan
Shares Cleveland Clinic Taussig Cancer Institute, Non-small-cell lung cancer.
- PersonReinhard Büttner
Shares Comprehensive genomic profiling, Non-small-cell lung cancer.
- PersonCharu Aggarwal
Shares Comprehensive genomic profiling, Non-small-cell lung cancer.
- PersonWoong-Yang Park
Shares Comprehensive genomic profiling, Non-small-cell lung cancer.
- PersonTakashi Kohno
Shares Comprehensive genomic profiling, Non-small-cell lung cancer.
- InstitutionHealthCare Global Enterprises
Shares Comprehensive genomic profiling, Non-small-cell lung cancer.
- InstitutionRajiv Gandhi Cancer Institute and Research Centre
Shares Comprehensive genomic profiling, Non-small-cell lung cancer.
- PersonJürgen Wolf
Shares Comprehensive genomic profiling, Non-small-cell lung cancer.